Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiomyopathy in Becker muscular dystrophy].

C Sakata1, H Yamada, N Sunohara

  • 1Department of Neurology, National Center of Neurology and Psychiatry.

Rinsho Shinkeigaku = Clinical Neurology
|September 1, 1990
PubMed
Summary

Becker muscular dystrophy (BMD) patients often develop heart problems like dilated cardiomyopathy, regardless of muscle weakness severity. Early cardiac monitoring is crucial for all BMD patients due to poor prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphodiesterase type III inhibitor enhances the protective effects of adenosine against ischemic hepatic injury in rats.

Transplantation proceedings·2001
Same author

The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma.

Surgery today·2000
Same author

Post-ischemic intraportal adenosine administration protects against reperfusion injury of canine liver.

Journal of hepato-biliary-pancreatic surgery·2000
Same author

Effects of adenosine on dopamine-induced hepatic impairment in the dog model.

Transplantation proceedings·1999
Same author

Effect of intraportal infusion of adenosine on hepatic blood flow and injury after ischemia and reperfusion of canine liver.

Transplantation proceedings·1999
Same author

Effect of intraportal infusion of adenosine on hepatic blood flow and injury after ischemia and reperfusion of canine liver.

Transplantation proceedings·1999

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Context:

  • Becker muscular dystrophy (BMD) is a genetic neuromuscular disorder.
  • Cardiac involvement, specifically dilated cardiomyopathy (DCM), is a known complication.
  • The relationship between cardiac and muscular symptoms in BMD requires further elucidation.

Purpose:

  • To investigate the clinical features and prognosis of cardiac involvement in Becker muscular dystrophy.
  • To compare patients with and without dilated cardiomyopathy within a BMD cohort.
  • To determine if clinical parameters predict cardiac complications in BMD.

Summary:

  • Three of six Becker muscular dystrophy patients presented with dilated cardiomyopathy.
  • No significant differences in age of onset, disease duration, muscle weakness severity, or dystrophin levels were observed between DCM and non-DCM groups.

Related Experiment Videos

  • Cardiac symptoms in a larger cohort (14 patients) appeared between ages 4-41 (average 17.1), with no correlation to muscle weakness severity.

    • Impact:

    • Becker muscular dystrophy patients with cardiomyopathy have a poor prognosis, with heart failure and cardiac transplantation being significant outcomes.
    • Myocardial involvement in BMD is not directly related to the clinical severity or duration of muscle disease.
    • Routine cardiac function monitoring is essential for all Becker muscular dystrophy patients, even those with mild muscle weakness, to detect early signs of cardiomyopathy.